Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines

Mao Wen Weng, Ji Ching Lai, Chung Ping Hsu, Kuan Ying Yu, Chih Yi Chen, Tong Sen Lin, Wu Wei Lai, Huei Lee, Jiunn Liang Ko

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The MDM2 gene is overexpressed in several human tumors and its product may be processed into various isoforms. Recently, alternative splicing forms of MDM2 mRNA have been detected in various types of tumors. In this study, lung tissue from human non small cell lung cancers was examined for MDM2 mRNA splicing variants by nested RT-PCR. Of the 117 lung cancer tissue samples analyzed, a total of 31 (26.5%) had splice variants for the MDM2 gene, while 59 (50.4%) had undetectable levels of MDM2 transcript. Further analysis indicated that the predominant variant for 26 of the 31 samples with alternative MDM2 splicing products was MDM2-657, a splice variant lacking exons 3-11. Significant associations were found between the frequency of alternative splicing and the gender and smoking habits of the patients. Approximately 36% of male patients had alternative splicing of MDM2 compared with only 9.5% of female patients (P = 0.008); 44.2% of the smoker patients had alternative MDM2 splice forms versus 16.2% of nonsmokers (P = 0.003). Furthermore, most normal lung cell lines examined possessed only full-length MDM2 mRNA, while among several lung cancer cell lines, only H1355 and CaLu-1 cells lacked alternatively spliced MDM2 transcripts. When H1355 cells were treated in vitro with the cigarette smoke carcinogen benzo[a]pyrene (B[a]P) or the B[a]P metabolite benzo[a]pyrene diolepoxide (BPDE), three MDM2 splicing products were detected by nested RT-PCR. Finally, with the use of several specific inhibitors, we found that BPDE-induced MDM2 mRNA alternative splicing in H1355 cells may occur through the PI3K or MAPK pathway. Overall, our results suggest that carcinogens present in cigarette smoke increase the risk of alternative MDM2 splicing, which is highly associated with lung cancer.

Original languageEnglish
Pages (from-to)1-11
Number of pages11
JournalEnvironmental and Molecular Mutagenesis
Volume46
Issue number1
DOIs
Publication statusPublished - Jul 2005
Externally publishedYes

Fingerprint

Benzo(a)pyrene
Alternative Splicing
pyrene
cancer
Cells
Carcinoma
Cell Line
Lung
Messenger RNA
carcinogen
Metabolites
tumor
Smoke
Tobacco Products
smoke
Carcinogens
Tumors
Lung Neoplasms
metabolite
Genes

Keywords

  • Acceptor site
  • Benzo[a]pyrene
  • MDM2
  • mRNA splicing
  • Non small cell lung cancer

ASJC Scopus subject areas

  • Environmental Science(all)
  • Environmental Chemistry
  • Genetics
  • Genetics(clinical)
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Weng, M. W., Lai, J. C., Hsu, C. P., Yu, K. Y., Chen, C. Y., Lin, T. S., ... Ko, J. L. (2005). Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines. Environmental and Molecular Mutagenesis, 46(1), 1-11. https://doi.org/10.1002/em.20118

Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines. / Weng, Mao Wen; Lai, Ji Ching; Hsu, Chung Ping; Yu, Kuan Ying; Chen, Chih Yi; Lin, Tong Sen; Lai, Wu Wei; Lee, Huei; Ko, Jiunn Liang.

In: Environmental and Molecular Mutagenesis, Vol. 46, No. 1, 07.2005, p. 1-11.

Research output: Contribution to journalArticle

Weng, MW, Lai, JC, Hsu, CP, Yu, KY, Chen, CY, Lin, TS, Lai, WW, Lee, H & Ko, JL 2005, 'Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines', Environmental and Molecular Mutagenesis, vol. 46, no. 1, pp. 1-11. https://doi.org/10.1002/em.20118
Weng, Mao Wen ; Lai, Ji Ching ; Hsu, Chung Ping ; Yu, Kuan Ying ; Chen, Chih Yi ; Lin, Tong Sen ; Lai, Wu Wei ; Lee, Huei ; Ko, Jiunn Liang. / Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines. In: Environmental and Molecular Mutagenesis. 2005 ; Vol. 46, No. 1. pp. 1-11.
@article{73f0740582bd4d1b8ee77c47f302fd4b,
title = "Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines",
abstract = "The MDM2 gene is overexpressed in several human tumors and its product may be processed into various isoforms. Recently, alternative splicing forms of MDM2 mRNA have been detected in various types of tumors. In this study, lung tissue from human non small cell lung cancers was examined for MDM2 mRNA splicing variants by nested RT-PCR. Of the 117 lung cancer tissue samples analyzed, a total of 31 (26.5{\%}) had splice variants for the MDM2 gene, while 59 (50.4{\%}) had undetectable levels of MDM2 transcript. Further analysis indicated that the predominant variant for 26 of the 31 samples with alternative MDM2 splicing products was MDM2-657, a splice variant lacking exons 3-11. Significant associations were found between the frequency of alternative splicing and the gender and smoking habits of the patients. Approximately 36{\%} of male patients had alternative splicing of MDM2 compared with only 9.5{\%} of female patients (P = 0.008); 44.2{\%} of the smoker patients had alternative MDM2 splice forms versus 16.2{\%} of nonsmokers (P = 0.003). Furthermore, most normal lung cell lines examined possessed only full-length MDM2 mRNA, while among several lung cancer cell lines, only H1355 and CaLu-1 cells lacked alternatively spliced MDM2 transcripts. When H1355 cells were treated in vitro with the cigarette smoke carcinogen benzo[a]pyrene (B[a]P) or the B[a]P metabolite benzo[a]pyrene diolepoxide (BPDE), three MDM2 splicing products were detected by nested RT-PCR. Finally, with the use of several specific inhibitors, we found that BPDE-induced MDM2 mRNA alternative splicing in H1355 cells may occur through the PI3K or MAPK pathway. Overall, our results suggest that carcinogens present in cigarette smoke increase the risk of alternative MDM2 splicing, which is highly associated with lung cancer.",
keywords = "Acceptor site, Benzo[a]pyrene, MDM2, mRNA splicing, Non small cell lung cancer",
author = "Weng, {Mao Wen} and Lai, {Ji Ching} and Hsu, {Chung Ping} and Yu, {Kuan Ying} and Chen, {Chih Yi} and Lin, {Tong Sen} and Lai, {Wu Wei} and Huei Lee and Ko, {Jiunn Liang}",
year = "2005",
month = "7",
doi = "10.1002/em.20118",
language = "English",
volume = "46",
pages = "1--11",
journal = "Environmental and Molecular Mutagenesis",
issn = "0893-6692",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines

AU - Weng, Mao Wen

AU - Lai, Ji Ching

AU - Hsu, Chung Ping

AU - Yu, Kuan Ying

AU - Chen, Chih Yi

AU - Lin, Tong Sen

AU - Lai, Wu Wei

AU - Lee, Huei

AU - Ko, Jiunn Liang

PY - 2005/7

Y1 - 2005/7

N2 - The MDM2 gene is overexpressed in several human tumors and its product may be processed into various isoforms. Recently, alternative splicing forms of MDM2 mRNA have been detected in various types of tumors. In this study, lung tissue from human non small cell lung cancers was examined for MDM2 mRNA splicing variants by nested RT-PCR. Of the 117 lung cancer tissue samples analyzed, a total of 31 (26.5%) had splice variants for the MDM2 gene, while 59 (50.4%) had undetectable levels of MDM2 transcript. Further analysis indicated that the predominant variant for 26 of the 31 samples with alternative MDM2 splicing products was MDM2-657, a splice variant lacking exons 3-11. Significant associations were found between the frequency of alternative splicing and the gender and smoking habits of the patients. Approximately 36% of male patients had alternative splicing of MDM2 compared with only 9.5% of female patients (P = 0.008); 44.2% of the smoker patients had alternative MDM2 splice forms versus 16.2% of nonsmokers (P = 0.003). Furthermore, most normal lung cell lines examined possessed only full-length MDM2 mRNA, while among several lung cancer cell lines, only H1355 and CaLu-1 cells lacked alternatively spliced MDM2 transcripts. When H1355 cells were treated in vitro with the cigarette smoke carcinogen benzo[a]pyrene (B[a]P) or the B[a]P metabolite benzo[a]pyrene diolepoxide (BPDE), three MDM2 splicing products were detected by nested RT-PCR. Finally, with the use of several specific inhibitors, we found that BPDE-induced MDM2 mRNA alternative splicing in H1355 cells may occur through the PI3K or MAPK pathway. Overall, our results suggest that carcinogens present in cigarette smoke increase the risk of alternative MDM2 splicing, which is highly associated with lung cancer.

AB - The MDM2 gene is overexpressed in several human tumors and its product may be processed into various isoforms. Recently, alternative splicing forms of MDM2 mRNA have been detected in various types of tumors. In this study, lung tissue from human non small cell lung cancers was examined for MDM2 mRNA splicing variants by nested RT-PCR. Of the 117 lung cancer tissue samples analyzed, a total of 31 (26.5%) had splice variants for the MDM2 gene, while 59 (50.4%) had undetectable levels of MDM2 transcript. Further analysis indicated that the predominant variant for 26 of the 31 samples with alternative MDM2 splicing products was MDM2-657, a splice variant lacking exons 3-11. Significant associations were found between the frequency of alternative splicing and the gender and smoking habits of the patients. Approximately 36% of male patients had alternative splicing of MDM2 compared with only 9.5% of female patients (P = 0.008); 44.2% of the smoker patients had alternative MDM2 splice forms versus 16.2% of nonsmokers (P = 0.003). Furthermore, most normal lung cell lines examined possessed only full-length MDM2 mRNA, while among several lung cancer cell lines, only H1355 and CaLu-1 cells lacked alternatively spliced MDM2 transcripts. When H1355 cells were treated in vitro with the cigarette smoke carcinogen benzo[a]pyrene (B[a]P) or the B[a]P metabolite benzo[a]pyrene diolepoxide (BPDE), three MDM2 splicing products were detected by nested RT-PCR. Finally, with the use of several specific inhibitors, we found that BPDE-induced MDM2 mRNA alternative splicing in H1355 cells may occur through the PI3K or MAPK pathway. Overall, our results suggest that carcinogens present in cigarette smoke increase the risk of alternative MDM2 splicing, which is highly associated with lung cancer.

KW - Acceptor site

KW - Benzo[a]pyrene

KW - MDM2

KW - mRNA splicing

KW - Non small cell lung cancer

UR - http://www.scopus.com/inward/record.url?scp=23244442254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23244442254&partnerID=8YFLogxK

U2 - 10.1002/em.20118

DO - 10.1002/em.20118

M3 - Article

VL - 46

SP - 1

EP - 11

JO - Environmental and Molecular Mutagenesis

JF - Environmental and Molecular Mutagenesis

SN - 0893-6692

IS - 1

ER -